MONA RUIZ: Open Payments
NPI 1720744162 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 10 payments from 10 companies in 2025. Trend: 2023 $232 · 2024 $167 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Neurelis, Inc. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| CeQur Corporation | 1 | $9 |
Products named: BEXSERO, GIVLAARI, APTIMA, VALTOCO, ACCRUFER, DAWNZERA, NURTEC ODT, FARXIGA.
Industry payments across CA — which companies pay providers there.
